Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
Conditions: Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus InfectionInterventions: Biological: Comparator: GARDASIL; Biological: Experimental: V503Sponsor: Merck Sharp & Dohme Corp.Active, not recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer Vaccine | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Research | Study | Vaccines | Vaginal Cancer | Vulvar Cancer | Warts | Women